Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
Craig L. Leonardi(Saint Louis University), Alexa B. Kimball(Harvard University), Kim Papp(Western University), Newman Yeilding, Cynthia Guzzo, Yuhua Wang, Shu Li, Lisa T. Dooley, Kenneth B. Gordon(NorthShore University HealthSystem)
Cited by 1,863
Abstract
Related Papers
No related papers found
Powered by citation graph analysis